Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
J Ocul Pharmacol Ther ; 33(8): 629-634, 2017 10.
Article in English | MEDLINE | ID: mdl-28704121

ABSTRACT

PURPOSE: The aim of this study was to elucidate in vitro antiamoebic activity of antimicrobial agents at short exposure times similar to those used for actual treatment against Acanthamoeba strains isolated from patients with keratitis. METHODS: The 5 clinical Acanthamoeba isolated in Japan were used in this study. Identification of genotypes for the Acanthamoeba isolates was performed using partial 18S ribosomal DNA (rDNA), including the ASA.S1 region sequences. Fluconazole, miconazole, itraconazole, voriconazole, amphotericin B, natamycin (pimaricin), and micafungin (antifungal agents), and chlorhexidine (a biguanide disinfectant), and sulfamethoxazole and paromomycin (antibacterial agents) were used to determine the antiamoebic activity against Acanthamoeba, which were determined by 50% and 90% growth inhibitory concentrations (IC50 and IC90) following exposing to each drug at 25°C for 7 days and 12 h. RESULTS: Among the tested antimicrobial agents, natamycin strongly inhibited the growth of all Acanthamoeba isolates at low concentration in both the 7-day (IC90 = 4.1 µg/mL) and 12-h (IC90 = 11.6 µg/mL) assays. Additionally, sulfamethoxazole exhibited strong antiamoebic activity (IC90 = 9.8 µg/mL) at low concentration in the 7-day assay. CONCLUSIONS: Our findings showed that natamycin ophthalmic solution might be an effective agent against Acanthamoeba keratitis. Additionally, frequent administration of sulfamethoxazole ophthalmic solution or systemic sulfamethoxazole-trimethoprim is also considered as an effective treatment for Acanthamoeba keratitis.


Subject(s)
Acanthamoeba Keratitis/drug therapy , Acanthamoeba/drug effects , Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Acanthamoeba/genetics , Acanthamoeba/isolation & purification , Acanthamoeba Keratitis/parasitology , Amebicides/administration & dosage , Amebicides/pharmacology , Anti-Bacterial Agents/administration & dosage , Antifungal Agents/administration & dosage , Genotype , Humans , In Vitro Techniques , Inhibitory Concentration 50 , Japan , Ophthalmic Solutions , RNA, Ribosomal, 18S/genetics , Time Factors
2.
Kansenshogaku Zasshi ; 87(1): 33-8, 2013 Jan.
Article in Japanese | MEDLINE | ID: mdl-23484376

ABSTRACT

Clostridium tetani is widely distributed in ground or mud, especially in field and pond-shore surface layers. C. tetani is rarely isolated from specimens of patients with tetanus, and is generally diagnosed based on clinical symptoms such as trismus or general tonic spasms. This means that positive C. tetani infection is rarely diagnosed bacterially. Using gram straing, we identified C. tetani in specimens from patients suspected of C. tetani infection brought to the Kitasato University Hospital emergency center. Rapid gram staining information in the bacteriology laboratory is expected to improve recovery from C. tetani infection. It is therefore necessary to ensure clinical specimen quality control, and to keep standard strains of rare bacteria for isolation and identification.


Subject(s)
Clostridium tetani/isolation & purification , Tetanus/microbiology , Adult , Humans , Male , Microbial Sensitivity Tests , Penicillin G/therapeutic use , Tetanus/drug therapy , Treatment Outcome
3.
Kansenshogaku Zasshi ; 86(5): 555-62, 2012 Sep.
Article in Japanese | MEDLINE | ID: mdl-23198574

ABSTRACT

We report herein on the isolation of three linezolid-resistant Enterococcus faecalis strains in 2011 from two pediatric inpatients at Kitasato University Hospital, Japan. Three linezolid resistant strains were isolated from two patients who shared the same room of a pediatric inpatient ward. Two linezolid resistant strains were isolated from patient A who had been treated with a total of 17,600mg of linezolid during 60 days of hospitalization (strains 1 and 2). The linezolid resistant E. faecalis persisted through the time that the patient had been discharged from the hospital. Another linezolid resistant strain was isolated from patient B who had no history of linezolid administration. The resistant strain in patient B phased out spontaneously. The minimum inhibitory concentration of linezolid in these strains ranged from 8.0 to 16.0 microg/mL. PCR amplification of the chromosomal gene encoding domain V of the 23S rRNA and subsequent nucleotide sequencing revealed that all the strains had at least one G2576T mutation. The pulse-field-gel electrophoretograms of the DNA treated with the SmaI restriction enzyme showed an identical profile suggesting that they were derived from a single resistant strain. These results suggested that the resistant strain occurred in patient A and was transmitted to patient B within the inpatient ward.


Subject(s)
Acetamides/pharmacology , Anti-Infective Agents/pharmacology , Enterococcus faecalis/drug effects , Oxazolidinones/pharmacology , Child , Child, Preschool , Drug Resistance, Bacterial , Electrophoresis, Gel, Pulsed-Field , Enterococcus faecalis/chemistry , Enterococcus faecalis/genetics , Enterococcus faecalis/isolation & purification , Female , Humans , Linezolid , Male , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...